本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Pasithea Therapeutics Corp.

1.69
-0.0400-2.31%
盤後1.740.0500+2.96%18:28 EDT
成交量:18.44萬
成交額:32.04萬
市值:457.19萬
市盈率:-0.13
高:1.80
開:1.71
低:1.55
收:1.73
資料載入中...
2022/06/01

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/05/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/21

重要事件披露

8-K - Current report
2021/12/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/14

SEC問詢函

CORRESP [Cover] - Correspondence
2021/12/09

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/11/29

重要事件披露

8-K - Current report
2021/11/18

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/22

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/13

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/10

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/10

SEC問詢函

CORRESP [Cover] - Correspondence
2021/09/10

SEC問詢函

CORRESP [Cover] - Correspondence
2021/08/27

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses